These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 11896503)

  • 81. [Is the aldosterone-renin ratio useful in screening for primary aldosteronism?].
    Kreze A; Okálová D; Hrnclar J
    Vnitr Lek; 1996 Sep; 42(9):649-51. PubMed ID: 8984776
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Screening for primary aldosteronism in an argentinian population: a multicenter prospective study.
    Leal Reyna M; Gómez RM; Lupi SN; Belli SH; Fenili CA; Martínez MS; Ruibal GF; Rossi MA; Chervin RA; Cornaló D; Contreras LN; Costa L; Nofal MT; Damilano SA; Pardes EM
    Arch Endocrinol Metab; 2015 Oct; 59(5):441-7. PubMed ID: 26222233
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers.
    Gordon RD; Ziesak MD; Tunny TJ; Stowasser M; Klemm SA
    Clin Exp Pharmacol Physiol; 1993 May; 20(5):296-8. PubMed ID: 8324912
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Clinical relevance of dietary salt intake on aldosterone and the aldosterone-to-renin ratio as screening parameters for primary aldosteronism.
    Koch M; Aker S; Haastert B; Rump LC
    Clin Nephrol; 2010 Sep; 74(3):182-9. PubMed ID: 20860902
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Diagnosis and therapy of arterial hypertension. Significance of the renin-angiotensin-aldosterone system in differential diagnosis and therapy].
    Nast HP; Philipp T
    Fortschr Med; 1974 Apr; 92(11):447-51. PubMed ID: 4362672
    [No Abstract]   [Full Text] [Related]  

  • 86. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.
    Mulatero P; Stowasser M; Loh KC; Fardella CE; Gordon RD; Mosso L; Gomez-Sanchez CE; Veglio F; Young WF
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1045-50. PubMed ID: 15001583
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Reference intervals for aldosterone, renin, and the aldosterone-to-renin ratio in the population-based Study of Health in Pomerania (SHIP-1).
    Hannemann A; Friedrich N; Lüdemann J; Völzke H; Rettig R; Peters J; Reincke M; Döring A; Nauck M; Wallaschofski H
    Horm Metab Res; 2010 Jun; 42(6):392-9. PubMed ID: 20157876
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Feasibility of primary aldosteronism diagnosis in initial evaluation without medication withdrawal or confirmatory tests.
    Ruiz-Sánchez JG; Fernández Sánchez Á; Meneses D
    Endocrine; 2024 Aug; 85(2):906-915. PubMed ID: 38568364
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Primary aldosteronism: the most frequent form of secondary hypertension?
    Shargorodsky M; Zimlichman R
    Isr Med Assoc J; 2002 Jan; 4(1):32-3. PubMed ID: 11802308
    [No Abstract]   [Full Text] [Related]  

  • 90. Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study.
    Lim PO; Jung RT; MacDonald TM
    Br J Clin Pharmacol; 1999 Nov; 48(5):756-60. PubMed ID: 10594479
    [TBL] [Abstract][Full Text] [Related]  

  • 91. MANAGEMENT OF ENDOCRINE DISEASE: The role of confirmatory tests in the diagnosis of primary aldosteronism.
    Morera J; Reznik Y
    Eur J Endocrinol; 2019 Feb; 180(2):R45-R58. PubMed ID: 30475220
    [TBL] [Abstract][Full Text] [Related]  

  • 92. High prevalence of primary aldosteronism in the Tayside hypertension clinic population.
    Lim PO; Dow E; Brennan G; Jung RT; MacDonald TM
    J Hum Hypertens; 2000 May; 14(5):311-5. PubMed ID: 10822317
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Factors affecting the aldosterone/renin ratio.
    Stowasser M; Ahmed AH; Pimenta E; Taylor PJ; Gordon RD
    Horm Metab Res; 2012 Mar; 44(3):170-6. PubMed ID: 22147655
    [TBL] [Abstract][Full Text] [Related]  

  • 94. PREVELENCE OF PRIMARY ALDOSTERONISM IN AN URBAN HYPERTENSIVE POPULATION.
    Galati SJ; Cheesman KC; Springer-Miller R; Hopkins SM; Krakoff L; Bagiella E; Zhuk RA; Ying TK; Amer C; Boyajian MK; Inabnet WB; Levine AC
    Endocr Pract; 2016 Nov; 22(11):1296-1302. PubMed ID: 27893293
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A cross-sectional study of the effects of β-blocker therapy on the interpretation of the aldosterone/renin ratio: can dosing regimen predict effect?
    Griffin TP; Browne GA; Wall D; Dennedy MC; OʼShea PM
    J Hypertens; 2016 Feb; 34(2):307-15. PubMed ID: 26867057
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Evaluation of aldosterone to direct renin ratio, low renin and related Phenotypes in Afro-Colombian patients with apparent treatment resistant hypertension.
    Durán CE; Bustamante M; Barbosa M; Useche EM; Triviño J; Sandoval L; Moncayo PA; Rivas AM; Zapata JS; Hernández Quintero JD; Meza S; Bolaños JS; Schweineberg J; Mesa L; Posada JG
    Sci Rep; 2024 Aug; 14(1):18091. PubMed ID: 39103362
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [New concepts in searching for primary aldosteronism in hypertension: advances in screening, confirming and subtyping tests].
    Zhu DL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):865-7. PubMed ID: 17217707
    [No Abstract]   [Full Text] [Related]  

  • 98. Prevalence of primary aldosteronism in unselected hypertensive populations: screening and definitive diagnosis.
    Ganguly A
    J Clin Endocrinol Metab; 2001 Aug; 86(8):4002-4. PubMed ID: 11502849
    [No Abstract]   [Full Text] [Related]  

  • 99. Primary aldosteronism in hypertensive patients: clinical implications and target therapy.
    Papanastasiou L; Markou A; Pappa T; Gouli A; Tsounas P; Fountoulakis S; Kounadi T; Tsiama V; Dasou A; Gryparis A; Samara C; Zografos G; Kaltsas G; Chrousos G; Piaditis G
    Eur J Clin Invest; 2014 Aug; 44(8):697-706. PubMed ID: 24909545
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The Aldosterone Renin Ratio (ARR) APP as Tool to Enhance the Detection Rate of Primary Aldosteronism.
    Rossi GP; Bisogni V
    High Blood Press Cardiovasc Prev; 2016 Jun; 23(2):147-9. PubMed ID: 26883242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.